HARMONY Alliance

@HarmonynetEU

European Public-Private Partnership for Data in | Funded by IMI, Innovative Medicines Initiative | 2017-2021

Vrijeme pridruživanja: siječanj 2017.

Tweetovi

Blokirali ste korisnika/cu @HarmonynetEU

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @HarmonynetEU

  1. Prikvačeni tweet
    17. svi 2018.

    This project receives funding from the Research & Innovation Programme. Any related tweets reflect only the views of the project owner.

    Poništi
  2. proslijedio/la je Tweet
    prije 5 sati

    Big Data in the heart of making healthcare better & affordable 👏👏 The main topic to be discussed at the UK-Spain Seminar ón Health Technologies Innovation

    Poništi
  3. proslijedio/la je Tweet

    Today is The Lymphoma Coalition, along with its members, is dedicated to creating equity in lymphoma outcomes across borders, ensuring patients with lymphoma receive the care and support they need. Learn more at

    Poništi
  4. proslijedio/la je Tweet
    prije 24 sata

    Like cancer, scientific breakthroughs can be decades in the making. It’s early days, but with 11 funded projects so far, IMI research will no doubt play a role in achieving the

    Poništi
  5. proslijedio/la je Tweet
    4. velj

    Did you know...? The cost of NOT having FAIR (findable, accessible, interoperable, reusable) data could be EUR 10 bn a year! This + other interesting facts in a presentation by our project at our SRG meeting in Brussels today.

    Poništi
  6. proslijedio/la je Tweet
    4. velj

    El proyecto europeo cumple 3 años. Su objetivo: juntar la mayoría de los datos posibles “de buena calidad”, para llevar a cabo un seguimiento de todas las enfermedades hematológicas malignas (cánceres de la sangre).

    Poništi
  7. proslijedio/la je Tweet
    4. velj

    Lack of quality data on blood cancers is a problem. Big data project is pooling data from across EU to better understand the different cancer subtypes, ultimately leading to better treatments.

    Poništi
  8. proslijedio/la je Tweet
    Poništi
  9. 4. velj

    HARMONY stands united with the oncology community on . Innovating and impactful using is being conducted across the globe, which will enable us to improve outcomes for patients.

    Poništi
  10. proslijedio/la je Tweet
    3. velj

    ⌛️Tomorrow, on – the will launch an EU-wide public consultation on Europe's Beating Cancer Plan! Find out more about the event that will start the consultation here & keep following the hashtag for updates:

    , , i još njih 7
    Poništi
  11. proslijedio/la je Tweet
    1. velj
    Poništi
  12. 31. sij

    A lot of exciting and collaborative discussions are taking place right now at the EHA-EBMT meeting. HARMONY is proud to be a part of the community! Meet us at the booth

    Poništi
  13. proslijedio/la je Tweet
    30. sij

    Round table discussion: Will an EU-wide harmonization process increase the number of clinical trials?

    Poništi
  14. 30. sij
    Poništi
  15. proslijedio/la je Tweet
    30. sij

    : After 2 interesting sessions on ✅Indications for CAR T cell therapy and ✅Improving the efficacy and safety profile, we just concluded a keynote lecture by Prof C Mackall on “Engineering next-generation CAR T cells to overcome resistance“.

    Poništi
  16. proslijedio/la je Tweet
    30. sij

    Only 2 days to submit your application for the Advocate Development Programme. This training programme includes attendance to the most important European scientific congresses for and advocates. Submit your application until 1 Feb!

    , , i još njih 3
    Poništi
  17. proslijedio/la je Tweet
    30. sij

    Good to.know about the increasing number of cell therapy treated patients registered in the Registry. is key to learn and improve patient outcomes

    Poništi
  18. proslijedio/la je Tweet
    14. sij

    Kicking off Pharmaledger, the project on enabled healthcare! Colm Carroll presents the big family of IMI projects, completed and ongoing ones. Quite impressive!

    Poništi
  19. proslijedio/la je Tweet
    29. sij

    2nd European CAR T Cell Meeting . There we are: start line to the premier EU event on CAR-T Cells and orher IEC therapies. 2nd edition sold out again Come, listen, share, learn, improve.

    Poništi
  20. proslijedio/la je Tweet
    28. sij
    Poništi
  21. proslijedio/la je Tweet
    28. sij

    YoungEHA committee chair and past chair Verena Gaidzik work with the National Societies on the representation and involvement of early career researchers and clinicians – mjesto: European Hematology Association

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·